Advertisement
Screener

Heartflow, Inc. (HTFL) Graph

Add as a preferred source on Google

HTFL Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $64.08M; Cost of revenue $10.89M; Research and development $26.26M; Selling, general and administrative $44.83M.
  • 2026-03-31: Revenue $52.59M; Cost of revenue $10.42M; Research and development $21.62M; Selling, general and administrative $42.57M.
  • 2025-12-31: Revenue $49.13M*; Cost of revenue $10.07M*; Research and development $18.66M*; Selling, general and administrative $38.15M*.
  • 2025-09-30: Revenue $46.28M; Cost of revenue $10.86M; Research and development $17.30M; Selling, general and administrative $33.22M.

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

HTFL revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Non Us$3.77MUS$60.31MRevenue$64.08MCost of revenue$10.89MGross profit$53.19MOperating expenses$71.09MOperating income-$17.90MOther income, net-$126.00KResearch & development$26.26MSelling, general& administrative$44.83MPre-tax income-$15.72MIncome tax$22.00KNet income-$15.74M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$64.08M$10.89M$26.26M$44.83M$71.09M$22.00K-$15.74M
2026-03-31$52.59M$10.42M$21.62M$42.57M$71.67M$23.00K-$27.38M
2025-12-31$49.13M*$10.07M*$18.66M*$38.15M*$56.81M*-$165.00K*-$24.39M*
2025-09-30$46.28M$10.86M$17.30M$33.22M$50.51M$30.00K-$50.85M
2025-06-30$43.42M$10.65M$15.03M$31.46M$46.49M$59.00K-$9.20M
2025-03-31$37.20M$9.26M$13.92M$31.52M$45.44M(m)-$32.34M
2024-09-30$32.93M$8.00M$11.86M$28.00M$39.87M$0.00-$19.14M
2024-06-30$31.05M$7.21M$9.93M$28.08M$38.02M$120.00K-$23.38M
2024-03-31(m)(m)(m)(m)(m)(m)-$20.93M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$116.67M$21.32M$47.88M$87.39M$142.76M$45.00K-$43.12M
2025-06-30$80.63M$19.91M$28.96M$62.98M$91.94M$59.00K-$41.54M
2024-06-30$57.90M$14.63M$19.38M$54.12M$73.50M$48.00K-$44.31M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$126.90M$30.77M$46.25M$96.20M$142.45M$89.00K-$92.40M
2024-09-30$90.83M$22.63M$31.24M$82.13M$113.36M$48.00K-$63.45M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$176.03M$40.84M$64.92M$134.34M$199.26M-$76.00K-$116.79M
2024-12-31$125.81M$31.36M$43.52M$112.15M$155.67M$53.00K-$96.43M
2023-12-31$87.17M$29.12M$35.85M$95.11M$130.97M$547.00K-$95.66M

Similar stocks

Stock NameCountryMarket CapPE Ratio
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
HAEMONETICS CORP (HAE)United States$4.821B36.52
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
AtriCure, Inc. (ATRC)United States$3.089B
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
Advertisement